Home > Research > Publications & Outputs > The case against meta-consent

Links

Text available via DOI:

View graph of relations

The case against meta-consent: not only do Ploug and Holm not answer it, they make it even stronger

Research output: Contribution to Journal/MagazineComment/debatepeer-review

Published

Standard

The case against meta-consent: not only do Ploug and Holm not answer it, they make it even stronger. / Manson, Neil.
In: Journal of Medical Ethics, Vol. 46, No. 9, 26.08.2020, p. 627-628.

Research output: Contribution to Journal/MagazineComment/debatepeer-review

Harvard

APA

Vancouver

Manson N. The case against meta-consent: not only do Ploug and Holm not answer it, they make it even stronger. Journal of Medical Ethics. 2020 Aug 26;46(9):627-628. Epub 2019 Dec 6. doi: 10.1136/medethics-2019-105955

Author

Bibtex

@article{0e43fb54d3f94c209722f278391c8f47,
title = "The case against meta-consent: not only do Ploug and Holm not answer it, they make it even stronger",
abstract = "In a recent article, I argued that Ploug and Holm{\textquoteright}s {\textquoteleft}meta-consent{\textquoteright} proposal should be rejected for biobank governance. This was because, although meta-consent is permissible, it is both burdensome and ethically omissible. There is no ethical reason why funders should undertake the additional costs. Ploug and Holm have sought to respond to these arguments. Here, it is noted that not only do they fail to adequately refuse the case against meta-consent, they fail to even engage with the arguments, either misunderstanding them or ignoring them. In their response, Ploug and Holm unwittingly provide the basis of an even stronger case against meta-consent. They argue that broad consent has a built in tendency to expire, while also holding that broad consent should be one of the options available in meta-consent. Meta-consent thus ends up being more like dynamic consent, but, arguably, even more burdensome and costly.",
keywords = "consent, Consent for Research, biobanking",
author = "Neil Manson",
year = "2020",
month = aug,
day = "26",
doi = "10.1136/medethics-2019-105955",
language = "English",
volume = "46",
pages = "627--628",
journal = "Journal of Medical Ethics",
issn = "0306-6800",
publisher = "BMJ Publishing Group",
number = "9",

}

RIS

TY - JOUR

T1 - The case against meta-consent

T2 - not only do Ploug and Holm not answer it, they make it even stronger

AU - Manson, Neil

PY - 2020/8/26

Y1 - 2020/8/26

N2 - In a recent article, I argued that Ploug and Holm’s ‘meta-consent’ proposal should be rejected for biobank governance. This was because, although meta-consent is permissible, it is both burdensome and ethically omissible. There is no ethical reason why funders should undertake the additional costs. Ploug and Holm have sought to respond to these arguments. Here, it is noted that not only do they fail to adequately refuse the case against meta-consent, they fail to even engage with the arguments, either misunderstanding them or ignoring them. In their response, Ploug and Holm unwittingly provide the basis of an even stronger case against meta-consent. They argue that broad consent has a built in tendency to expire, while also holding that broad consent should be one of the options available in meta-consent. Meta-consent thus ends up being more like dynamic consent, but, arguably, even more burdensome and costly.

AB - In a recent article, I argued that Ploug and Holm’s ‘meta-consent’ proposal should be rejected for biobank governance. This was because, although meta-consent is permissible, it is both burdensome and ethically omissible. There is no ethical reason why funders should undertake the additional costs. Ploug and Holm have sought to respond to these arguments. Here, it is noted that not only do they fail to adequately refuse the case against meta-consent, they fail to even engage with the arguments, either misunderstanding them or ignoring them. In their response, Ploug and Holm unwittingly provide the basis of an even stronger case against meta-consent. They argue that broad consent has a built in tendency to expire, while also holding that broad consent should be one of the options available in meta-consent. Meta-consent thus ends up being more like dynamic consent, but, arguably, even more burdensome and costly.

KW - consent

KW - Consent for Research

KW - biobanking

U2 - 10.1136/medethics-2019-105955

DO - 10.1136/medethics-2019-105955

M3 - Comment/debate

VL - 46

SP - 627

EP - 628

JO - Journal of Medical Ethics

JF - Journal of Medical Ethics

SN - 0306-6800

IS - 9

ER -